0 194

Cited 85 times in

SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter

DC FieldValueLanguage
dc.contributor.author김승일-
dc.date.accessioned2018-05-10T06:38:44Z-
dc.date.available2018-05-10T06:38:44Z-
dc.date.issued2012-
dc.identifier.issn1473-0197-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/158364-
dc.description.abstractCirculating tumor cells (CTCs) have gained increasing attention as physicians and scientists learn more about the role these extraordinarily rare cells play in metastatic cancer. In developing CTC technology, the critical criteria are high recovery rates and high purity. Current isolation methods suffer from an inherent trade-off between these two goals. Moreover, ensuring minimal cell stress and robust reproducibility is also important for the clinical application of CTCs. In this paper, we introduce a novel CTC isolation technology using selective size amplification (SSA) for target cells and a multi-obstacle architecture (MOA) filter to overcome this trade-off, improving both recovery rate and purity. We also demonstrate SSA-MOA's advantages in minimizing cell deformation during filter transit, resulting in more stable and robust CTC isolation. In this technique, polymer microbeads conjugated with anti-epithelial cell adhesion molecules (anti-EpCAM) were used to selectively size-amplify MCF-7 breast cancer cells, definitively differentiating from the white blood cells (WBCs) by avoiding the size overlap that compromises other size selection methods. 3 μm was determined to be the optimal microbead diameter, not only for size discrimination but also in maximizing CTC surface coverage. A multi-obstacle architecture filter was fabricated using silicon-on-glass (SOG) technology-a first such application of this fabrication technique-to create a precise microfilter structure with a high aspect ratio. The filter was designed to minimize cell deformation as simulation results predicted that cells captured via this MOA filter would experience 22% less moving force than with a single-obstacle architecture. This was verified by experiments, as we observed reliable cell capture and reduced cell deformation, with a 92% average recovery rate and 351 peripheral blood leukocytes (PBL) per millilitre (average). We expect the SSA-MOA platform to optimize CTC recovery rates, purity, and stability, increasing the sensitivity and reliability of such tests, thereby potentially expanding the utilization of CTC technologies in the clinic.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherRoyal Society of Chemistry-
dc.relation.isPartOfLAB ON A CHIP-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAntibodies, Immobilized/chemistry-
dc.subject.MESHAntibodies, Immobilized/immunology-
dc.subject.MESHAntigens, Neoplasm/immunology-
dc.subject.MESHAntigens, Neoplasm/metabolism-
dc.subject.MESHCell Adhesion Molecules/immunology-
dc.subject.MESHCell Adhesion Molecules/metabolism-
dc.subject.MESHCell Line, Tumor-
dc.subject.MESHCell Separation/instrumentation*-
dc.subject.MESHCell Separation/methods*-
dc.subject.MESHEpithelial Cell Adhesion Molecule-
dc.subject.MESHFiltration/methods*-
dc.subject.MESHGlass/chemistry-
dc.subject.MESHHumans-
dc.subject.MESHLeukocytes/cytology-
dc.subject.MESHMicrofluidic Analytical Techniques/instrumentation-
dc.subject.MESHMicrofluidic Analytical Techniques/methods-
dc.subject.MESHMicrospheres-
dc.subject.MESHNeoplastic Cells, Circulating*-
dc.subject.MESHPolymers/chemistry-
dc.subject.MESHSilicon/chemistry-
dc.titleSSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Surgery-
dc.contributor.googleauthorMinseok S. Kim-
dc.contributor.googleauthorTae Seok Sim-
dc.contributor.googleauthorYeon Jeong Kim-
dc.contributor.googleauthorSun Soo Kim-
dc.contributor.googleauthorHyoyoung Jeong-
dc.contributor.googleauthorJong-Myeon Park-
dc.contributor.googleauthorHui-Sung Moon-
dc.contributor.googleauthorSeung Il Kim-
dc.contributor.googleauthorOgan Gurel-
dc.contributor.googleauthorSoo Suk Lee-
dc.contributor.googleauthorJeong-Gun Lee-
dc.contributor.googleauthorJae Chan Park-
dc.identifier.doi10.1039/c2lc40065k-
dc.contributor.localIdA00658-
dc.relation.journalcodeJ02148-
dc.identifier.eissn1473-0189-
dc.identifier.pmid22684249-
dc.identifier.urlhttp://pubs.rsc.org/en/Content/ArticleLanding/2012/LC/c2lc40065k#!divAbstract-
dc.contributor.alternativeNameKim, Seung Il-
dc.contributor.affiliatedAuthorKim, Seung Il-
dc.citation.volume12-
dc.citation.number16-
dc.citation.startPage2874-
dc.citation.endPage2880-
dc.identifier.bibliographicCitationLAB ON A CHIP, Vol.12(16) : 2874-2880, 2012-
dc.identifier.rimsid40728-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.